A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. - Wikidata - awgldk - TriplyDB

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

http://www.wikidata.org/entity/Q34976475

about

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line Characterization of extracellular circulating microRNA Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention The role of microRNAs in bladder cancer Aberrantly expressed microRNAs in the context of bladder tumorigenesis Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise Diagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-Analysis Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids MicroRNAs and triple negative breast cancer Extracellular microRNAs in urologic malignancies: chances and challenges MicroRNAs as biomarkers for myocardial infarction Clinical and pathological implications of miRNA in bladder cancer Intercellular transport of microRNAs MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study Detection of circulating parasite-derived microRNAs in filarial infections Export of microRNAs and microRNA-protective protein by mammalian cells The microRNA spectrum in 12 body fluids Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma Potential new urinary markers in the early detection of bladder cancer.Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.MicroRNAs in biofluids are novel tools for bladder cancer screening.Strengths and limitations of laboratory procedures for microRNA detection A knowledge base for the discovery of function, diagnostic potential and drug effects on cellular and extracellular miRNAs Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Comprehensive reconstruction and visualization of non-coding regulatory networks in human.Serum microRNA profiles in children with autism.MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis.Noninvasive micromarkers Elevated levels of miR-155 in blood and urine from patients with nephrolithiasis.miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.MicroRNAs as biomarkers in colorectal cancer

P2860

Q21129476-FDB2E114-D6D1-489A-B464-2B35EF5FA6A5 Q21136096-1586F62C-B758-40DF-918A-50C3B609221B Q24603537-28133EF0-7A81-4680-94A9-098092B97FF5 Q26742027-8DA86A67-6230-4075-88C4-7FD6BD94D663 Q26744149-DBDA51CF-B702-41BD-83E5-758A7D8DA826 Q26744152-331F5EFE-5254-481E-BC59-798920ECDE89 Q26775990-25307B57-972D-4FD1-864D-FB415357EB8F Q26786185-FE675372-FE8F-41EA-88F2-0F9D988AEF70 Q26796590-D03FAA0A-8ECE-4B47-B0B8-281CCCB08EB3 Q26825022-3303433E-3CD9-4E43-A18E-94B806CA12D0 Q26862716-82FBFB8A-469D-4A73-8D21-E763F789DBC9 Q26866043-A53D027E-D458-4F3B-A600-EA12312B0FF1 Q27000432-CDBE12C1-75F4-4FD3-A072-91DD038D1D27 Q27004262-3F25DA85-CD90-488B-BCD5-AF6E369408D4 Q27004360-10B5D03B-E571-4190-8563-72840A6FAC67 Q27025580-8547462A-4A8C-4FB6-A061-5D1148162B7A Q28081081-F7B4CFEF-1588-477A-BD98-8B78FB1A1E4B Q28395462-96B276AA-9F75-4EB0-9BD7-706639E6AA1F Q28655587-00F6FA35-DBBB-47FB-B726-4445E67A56CC Q29614234-89E9298D-20E8-4628-9D8B-B36CD8604EF0 Q29618068-DC450FF5-EAF5-44C5-B9FA-8E37244AC14C Q33566895-40E3A763-D88B-4680-8ACD-6D01BE16EF9D Q33653161-17AB44F6-A8A6-466A-9612-8D00A8E4825D Q33657098-BD451F3F-9F48-40C4-886A-2A16542F395D Q33689126-B71EC1AE-17E6-4A7E-906A-1211F4843891 Q33732120-65762CD6-7448-463E-9FC4-B8FB3761910B Q33750895-74B09824-6B80-4C06-BFB8-CCBDBEE687F0 Q33762123-3FF739FA-8B02-46B1-AF31-FD7967E8FDA9 Q33780712-75EA7644-AEC9-409E-94B3-76521CE39958 Q33851551-0F0EABE7-3447-45DC-9D12-CDE871FEBF66 Q33889872-EDD40640-15E6-4C3E-9867-361776542930 Q33962495-6088021B-DD38-47D1-B66D-5CA79A9C79B4 Q34039254-65C2C346-D7AF-486C-A200-369610705097 Q34042865-7E9E7EA7-F62D-49EF-9A1C-604C92CA2DAE Q34043327-B82CBA19-6D3C-4C46-9492-D60B6FE1AC4D Q34078121-DA69D458-1A9B-4C98-B76C-DFDFFE781384 Q34111606-2C9A7DDF-B2F6-42CF-BF5C-8494B32901B3 Q34114226-A2975BAE-AA69-4D34-B8AF-58BED5A78580 Q34157084-7EB7FE92-3576-4C49-B9AE-EEF8A2F7CD66 Q34162262-D402C272-8694-4C35-914E-F69FF3E86FCA

P2860

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

http://www.wikidata.org/entity/Q34976475

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A robust methodology to study ...... ted to urinary bladder cancer.

@ast

A robust methodology to study ...... ted to urinary bladder cancer.

@en

A robust methodology to study ...... ted to urinary bladder cancer.

@nl

type

label

A robust methodology to study ...... ted to urinary bladder cancer.

@ast

A robust methodology to study ...... ted to urinary bladder cancer.

@en

A robust methodology to study ...... ted to urinary bladder cancer.

@nl

prefLabel

A robust methodology to study ...... ted to urinary bladder cancer.

@ast

A robust methodology to study ...... ted to urinary bladder cancer.

@en

A robust methodology to study ...... ted to urinary bladder cancer.

@nl

P1433

Q34976475-10938989-D0D6-431A-921F-1A341E75B634

P1476

Q34976475-F041CAEE-A82B-4BC0-8FB4-14F761FEBFA6

P2093

Q34976475-016CC8CE-7CC9-45AB-90D3-6491EFEE2CF9

Q34976475-47D8923F-934B-41C6-8496-624DB22EBEAD

Q34976475-482CAA69-5C97-4A77-8E26-A046C9C86D47

Q34976475-6FA25233-BCE9-490D-BF4B-34CBC3F588D4

Q34976475-84AA50D2-EAD6-4001-81C6-6ACBF5CE6F5C

Q34976475-9A02954E-8D5A-4A98-B803-199B29B68CD6

Q34976475-ACFA6F0A-64C6-4DF9-A4F6-D39D6F929112

Q34976475-B0C12CB8-E625-4DC1-8514-CADC26CC7752

P304

Q34976475-694D5C71-9051-4E3A-AC41-D5495FD0AD1C

P31

Q34976475-C211BADC-6589-473E-80B9-9EE09FFF4B1D

P356

Q34976475-1F8DFA34-74CF-454D-96CB-2C9E94C5F0E0

P433

Q34976475-248949A7-05AB-4178-8227-4D09B63580B0

P478

Q34976475-64CE3152-B184-489F-BCC7-DCAD0C40AC37

P577

Q34976475-84400460-8CDC-4DDA-B70D-54693CE9874A

P5875

Q34976475-EF2DEF61-AECF-4D56-916A-F2A71FF4EDB4

P698

Q34976475-8A0804C7-10C9-483B-BEC4-21C7B7C1D174

P921

Q34976475-6EF2E4E7-58CE-4A7F-AA20-171931C28D36

P356

J.UROLONC.2009.01.027

P1433

Urologic Oncology

P1476

A robust methodology to study ...... ted to urinary bladder cancer.

@en

P2093

Alfred C Feller

http://www.w3.org/2001/XMLSchema#string

Dieter Jocham

http://www.w3.org/2001/XMLSchema#string

Georg Sczakiel

http://www.w3.org/2001/XMLSchema#string

Hartmut Merz

http://www.w3.org/2001/XMLSchema#string

Ingo Kausch

http://www.w3.org/2001/XMLSchema#string

Jens M Warnecke

http://www.w3.org/2001/XMLSchema#string

Kai Hoefig

http://www.w3.org/2001/XMLSchema#string

Merle Hanke

http://www.w3.org/2001/XMLSchema#string

P304

655-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2009.01.027

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24307045

http://www.w3.org/2001/XMLSchema#string

P698

19375957

http://www.w3.org/2001/XMLSchema#string

P921